Differences between actual and predicted series of international trade in the EU countries during the COVID-19 pandemic (%). by Karolina Pawlak (13813008)

Subjects:

Metabolites with decreasing levels during the development. by Martin Sládek (130663)

Changes in best-corrected visual acuity and total area reduction ratio of the epiretinal membrane (ERM) during follow-up. by Su Hwan Park (15158181)

“…<p>(a) During the follow-up period, the stable group showed no significant change in visual acuity, whereas the progression group exhibited a decrease compared to baseline starting at 12 months, with greater changes than those in the stable group beginning at 6 months. …”

GTDE restored recognition memory against d-gal induced aging. by Hui-Chuan Kuo (12368492)

Subjects:

Illicit substance use by category pre-COVID and during-COVID among active users. by Megayn E. Lewandowski (18599144)

Subjects:

Self-reported life events pre-COVID and during-COVID among active users. by Megayn E. Lewandowski (18599144)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

Significantly downregulated-gene list in RNA-seq. by Tomoki Kawahata (18522588)

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

Subjects:

Statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

Propofol anesthesia or with surgery decreased the expression of p-CREB and SAHA reversed the reduction. by Yunlin Feng (3043659)

MSNA recording of one of the participants (patient 8, baseline). by Monique E. A. M. van Kleef (8783282)

Subjects:

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

Changes in FMD (% ± SD) in patient subgroup with decreased body weight during observation period. by Haruka Tamura (153793)

<b>Glucagon Clearance is Decreased in Chronic Kidney Disease, but Preserved in Liver Cirrhosis</b> by Magnus F. G. Grøndahl (19160825)

Raw data. by Saeedeh Abbasi (9423189)

Subjects:

Data. by Saeedeh Abbasi (9423189)

Subjects:

Weights did not vary significantly during PPS treatment. by Penny A. Rudd (10298691)

Statistically significant linear increase in use of antidementia medications and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Cigarette lighter heating of <i>S</i>. <i>aureus</i>-"spiked" Hydromorphone-CR prepared in cookers/filters decreases the bacterial burden in the injected drug solution. by Katherine J. Kasper (7181015)